Long-term leukemia trial reveals MRD-triggered treatment may slow or prevent relapse
With the publication of the long-term data from the RELAZA2 study, a research program developed over many years by Dresden University Medicine for the treatment of leukemia patients, has reached an important milestone. The ...
May 31, 2026
0
6









